Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-008 O2 mt D026"

From Bioblast
 
(10 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=NS(PGM)
|abbr=Q-junction mtprep
|description=[[File:1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd.png|400px]]
|description=[[File:1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd.png|600px]]
|info='''A:  SUIT protocol for mt; mt: isolated mitochondria and tissue homogenate - '''[[SUIT-008]]'''
|info='''A:  SUIT protocol for mt; mt: isolated mitochondria and tissue homogenate - '''[[SUIT-008]]'''
|SUIT number=D026_1PM;2D;2c;3G;4S;4D;5U;6Rot;7Ama;8AsTm;9Azd
|SUIT number=D026_1PM;2D;2c;3G;4S;4D;5U;6Rot;7Ama;8AsTm;9Azd
|application=O2
|application=O2
}}
}}
::: [[MitoPedia: SUIT]]
{{Template:SUIT text D026}}
::: '''[[Categories of SUIT protocols |SUIT-category]]:''' NS(PGM)
::: '''[[SUIT protocol pattern]]:''' diametral 1PM;2D;3G;4S;5U;6Rot-
 
The SUIT-008 O2 mt D026 protocol is designed to assess the additivity between the [[NADH_Electron_transfer-pathway_state| N-]] and [[Succinate pathway control state| S-pathway]] in the [[Q-junction]], providing a physiologically relevant estimate of maximum mitochondrial respiratory capacity. It also serves as a diagnostic tool for the activity of the glutamate dehydrogenase and its linked pathways, which could be relevant in some pathologies. SUIT-008 O2 mt D026 can be easily extended with the CIV assay module.


__TOC__
Communicated by [[Doerrier C]] and [[Gnaiger E]] (last update 2019-06-06)


__TOC__
== Representative traces ==
Communicated by [[Doerrier C]] and [[Gnaiger E]] (last update 2019-02-20)


[[File:D026 O2 traces.png|600px]]
{{Template:SUIT-008}}
{{Template:SUIT-008}}


Line 22: Line 20:
:::+ The presence of PGM and S establishes fully operative TCA cycle activity.
:::+ The presence of PGM and S establishes fully operative TCA cycle activity.
:::+ This protocol allows to analyse the convergence of pathways at the Q-junction (N, NS, S).
:::+ This protocol allows to analyse the convergence of pathways at the Q-junction (N, NS, S).
:::+ Outer mitochondrial membrane integrity can be evaluated by the addition of cytochrome ''c'' ([[Cytochrome c control factor |cytochrome ''c'' test]]). The early addition of cytochrome ''c''  in the protocol ensures comparability of all states in case of any effect of cytochrome ''c'.
:::+ Outer mitochondrial membrane integrity can be evaluated by the addition of cytochrome ''c'' ([[Cytochrome c control factor |cytochrome ''c'' test]]). The early addition of cytochrome ''c''  in the protocol ensures comparability of all states in case of any effect of cytochrome ''c''.
:::+ GM and PM yield typically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM: the fraction of the N-pathway is lower and S-pathway contribution is higher with GM compared to PM. PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-pathway, since impairment of N-pathway capacity can be compensated partially by activation of the S-pathway. This is an advantage compared to [[SUIT-011]] for the diagnosis of N-capacity.
:::+ GM and PM yield typically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM: the fraction of the N-pathway is lower and S-pathway contribution is higher with GM compared to PM. PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-pathway, since impairment of N-pathway capacity can be compensated partially by activation of the S-pathway. This is an advantage compared to [[SUIT-011]] for the diagnosis of N-capacity.
:::+ Reasonable duration of the experiment.
:::+ Reasonable duration of the experiment.
Line 30: Line 28:


== Compare SUIT protocols ==
== Compare SUIT protocols ==
::::* [[SUIT-014]]: 1GM;2D;3P;4S;5U;6Rot-; similar version starting with GM, and then adding P. Used in combination with SUIT-008 in [[Lemieux_2017_Sci_Rep|Lemieux 2017]] for [[Permeabilized muscle fibers|pfi]].
::::* [[SUIT-004]]: SUIT-004 protocol provide a quick assessment of the linear coupling control (''L''-''P''-''E'') with NADH linked-substrates (PM) and the pathway control in ET state (N, NS, S pathways).
::::* [[SUIT-004]]: SUIT-004 protocol provide a quick assessment of the linear coupling control (''L''-''P''-''E'') with NADH linked-substrates (PM) and the pathway control in ET state (N, NS, S pathways).
::::* [[SUIT-011]]: SUIT-011 protocol are designed to study physiologically relevant maximum mitochondrial respiratory capacity (OXPHOS capacity with GMS as NS-linked substrates).  
::::* [[SUIT-011]]: SUIT-011 protocol are designed to study physiologically relevant maximum mitochondrial respiratory capacity (OXPHOS capacity with GMS as NS-linked substrates).  
== Chemicals and syringes ==
{{Template:Chemicals SUIT-008}}
{{Template:Chemicals CIV}}
::: Suggested stock concentrations are shown in the specific DL-Protocol.


== References ==
== References ==

Latest revision as of 10:56, 17 September 2020


high-resolution terminology - matching measurements at high-resolution


SUIT-008 O2 mt D026

Description

1PM;2D;2c;3G;4S;5U;6Rot;7Ama;8AsTm;9Azd.png

Abbreviation: Q-junction mtprep

Reference: A: SUIT protocol for mt; mt: isolated mitochondria and tissue homogenate - SUIT-008

SUIT number: D026_1PM;2D;2c;3G;4S;4D;5U;6Rot;7Ama;8AsTm;9Azd

O2k-Application: O2

The SUIT-008 O2 mt D026 protocol can be used with mitochondrial preparations such as isolated mitochondria, tissue homogenates and permeabilized cells (already permeabilized when they are added to the chamber) in a wide variety of organisms and tissues. The protocol is designed to assess the additivity between the N- and S-pathway in the Q-junction, providing a physiologically relevant estimate of maximum mitochondrial respiratory capacity. It also serves as a diagnostic tool for the activity of the glutamate dehydrogenase and its linked pathways, which could be relevant in some pathologies. SUIT-008 O2 mt D026 can be easily extended with the CIV assay module.

Communicated by Doerrier C and Gnaiger E (last update 2019-06-06)

Representative traces

D026 O2 traces.png

MitoPedia: SUIT

Steps and respiratory states

SUIT-008

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1PM PML(n) N CI 1PM
2D PMP N CI 1PM;2D
2c PMcP N CI 1PM;2D;2c
3G PGMP N CI 1PM;2D;2c;3G
4S PGMSP NS CI&II 1PM;2D;2c;3G;4S
  • Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function.
  • OXPHOS capacity P (with saturating [ADP]), active OXPHOS state.
5U PGMSE NS CI&II 1PM;2D;2c;3G;4S;5U
6Rot SE S CII 1PM;2D;2c;3G;4S;5U;6Rot
7Ama ROX 1PM;2D;2c;3G;4S;5U;6Rot;7Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).
Step Respiratory state Pathway control ET-Complex Comment
## AsTm AsTmE CIV CIV
## Azd CHB


Questions.jpg


Click to expand or collaps

Strengths and limitations

+ NS-OXPHOS capacity provides a physiologically relevant estimate of maximum mitochondrial respiratory capacity.
+ The presence of PGM and S establishes fully operative TCA cycle activity.
+ This protocol allows to analyse the convergence of pathways at the Q-junction (N, NS, S).
+ Outer mitochondrial membrane integrity can be evaluated by the addition of cytochrome c (cytochrome c test). The early addition of cytochrome c in the protocol ensures comparability of all states in case of any effect of cytochrome c.
+ GM and PM yield typically identical fluxes in human skeletal muscle fibres. However, PM is the superior alternative to GM: the fraction of the N-pathway is lower and S-pathway contribution is higher with GM compared to PM. PM, therefore, yields a more sensitive assay for the diagnosis of injuries in the N-pathway, since impairment of N-pathway capacity can be compensated partially by activation of the S-pathway. This is an advantage compared to SUIT-011 for the diagnosis of N-capacity.
+ Reasonable duration of the experiment.
+ This protocol can be extended with the Complex IV module.
- F-pathway is not analysed.
- Careful washing is required after the experiment to avoid carry-over of inhibitors and uncoupler.

Compare SUIT protocols

  • SUIT-014: 1GM;2D;3P;4S;5U;6Rot-; similar version starting with GM, and then adding P. Used in combination with SUIT-008 in Lemieux 2017 for pfi.
  • SUIT-004: SUIT-004 protocol provide a quick assessment of the linear coupling control (L-P-E) with NADH linked-substrates (PM) and the pathway control in ET state (N, NS, S pathways).
  • SUIT-011: SUIT-011 protocol are designed to study physiologically relevant maximum mitochondrial respiratory capacity (OXPHOS capacity with GMS as NS-linked substrates).

Chemicals and syringes

Step Chemical(s) and link(s) Comments
1PM Pyruvate (P) and Malate (M)
2D ADP (D)
2c Cytochrome c (c)
3G Glutamate (G)
4S Succinate (S)
5U Carbonyl cyanide m-chlorophenyl hydrazone, CCCP (U) Can be substituted for other uncoupler
6Rot Rotenone (Rot)
7Ama Antimycin A (Ama)
Step Chemical(s) and link(s) Comments
## AsTm Ascorbate (As) and TMPD (Tm)
## Azd Azide (Azd)
Suggested stock concentrations are shown in the specific DL-Protocol.

References

MitoPedia concepts: SUIT protocol, SUIT A, Find 


MitoPedia methods: Respirometry